Shares of Cognition Therapeutics, Inc. (NASDAQ:CGTX – Get Free Report) were up 3.3% during trading on Monday . The firm’s fifty day moving average price is $1.17 and its 200-day moving average price is $1.15. On average, research analysts predict that Cognition Therapeutics, Inc. will post -0.32 earnings per share for the current year. By targeting a novel mechanism of action, Cognition Therapeutics aims to slow or reverse cognitive decline in patients living with Alzheimer’s disease. Recommended StoriesReceive News & Ratings for Cognition Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognition Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.